Lexaria Bioscience Corp. (LEXX) — Revenue

Annual figures by fiscal year, from SEC filings.

2020: $314.8K2021: $722.7K2022: $255.4K2023: $226.2K2024: $464.3K2025: $705.9K$705.9K
2020Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$705.9K+52.0%
2024$464.3K+105.2%
2023$226.2K-11.4%
2022$255.4K-64.7%
2021$722.7K+129.6%
2020$314.8K